LACTOSE (INDIA)
Back to Cashflow Statement
|
LACTOSE (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-0.29 Cr | ₹8.75 Cr | ₹7.89 Cr | ₹8.47 Cr | ₹2.17 Cr |
What is the latest Cash Flow from Operating Activities ratio of LACTOSE (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-0.29 Cr |
| Mar2024 | ₹8.75 Cr |
| Mar2023 | ₹7.89 Cr |
| Mar2022 | ₹8.47 Cr |
| Mar2021 | ₹2.17 Cr |
How is Cash Flow from Operating Activities of LACTOSE (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.29 Cr | Negative | |
| Mar2024 | ₹8.75 Cr | 10.79 | |
| Mar2023 | ₹7.89 Cr | -6.78 | |
| Mar2022 | ₹8.47 Cr | 291.09 | |
| Mar2021 | ₹2.17 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹116.7 Cr | -1% | -6.9% | -14.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -1% |
-6.9% |
-14.2% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses